Changes in Intestinal Permeability 4 Hours After Gluten Challenge
NCT03288831 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2019-06-07
Summary
This study evaluates why people with celiac disease and non-celiac gluten/wheat sensitivity develop rapid onset symptoms within hours of gluten exposure. Half of subjects will be given gluten and half will not.
Conditions
- Celiac Disease
- Wheat Hypersensitivity
- Gluten Sensitivity
- Gluten Enteropathy
- Immune System and Related Disorders
- Duodenal Diseases
Interventions
- DIETARY_SUPPLEMENT
-
Gluten
Six grams of gluten will be mixed with water and Tang flavoring. Subjects will drink the mixture one time.
- DIETARY_SUPPLEMENT
-
Placebo
Subjects will drink a mixture of rice water and Tang flavoring one time.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Joseph A. Murray, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-10
- Primary Completion
- 2018-10-30
- Completion
- 2018-10-30
Countries
- United States
Study Locations
More Related Trials
-
Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten Sensitivity
NCT01864993 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
NCT03521180 ·Status: COMPLETED
-
Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study
NCT02936297 ·Status: COMPLETED ·Phase: NA
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Dose-finding Gluten Challenge Trial in Nonceliac Gluten-sensitivity
NCT03188367 ·Status: UNKNOWN ·Phase: NA
-
GlutN : Randomized, Double-blind, Crossover Clinical Trial to Confirm the Role of Gluten in Non-celiac Gluten Sensitivity
NCT06347341 ·Status: TERMINATED ·Phase: NA
-
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
NCT00889473 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients
NCT03483805 ·Status: COMPLETED ·Phase: NA
-
Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Diet
NCT05066191 ·Status: UNKNOWN
-
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
NCT02472704 ·Status: COMPLETED ·Phase: NA
-
Treatment of Mild Enteropathy Celiac Disease
NCT00628823 ·Status: COMPLETED ·Phase: NA
-
Latiglutenase as a Treatment for Celiac Disease
NCT03585478 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
NCT06982963 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Coeliac Disease in Patients With Type 2 Diabetes
NCT06283264 ·Status: NOT_YET_RECRUITING
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects
NCT03798262 ·Status: COMPLETED ·Phase: NA
-
Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response?
NCT07039773 ·Status: RECRUITING ·Phase: NA
-
Quantification of Gluten Peptides in Feces
NCT02711397 ·Status: COMPLETED
-
In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease
NCT03168490 ·Status: TERMINATED ·Phase: NA
-
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
NCT04243551 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
NCT07298343 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Enzyme Supplements to Treat Celiac Disease
NCT00962182 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?
NCT06151782 ·Status: COMPLETED ·Phase: NA
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA